drugset / Trial / NCT01754545

Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura

NCT01754545

RandomizedCrossoverQuadruple-blindPrevention

Summary

Congenital thrombotic thrombocytopenic purpura (TTP), also called Upshaw-Schulman Syndrome or hereditary or familial TTP is a rare, but severe disease. The purpose of this study is to determine how infusions of plasma to patients with congenital TTP correlate with symptoms and signs of activity of the disease, and to determine why some patients need more frequent infusions of plasma than others to prevent acute attacks of the disease.

Timeline

Start
2012-09
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Octaplas LG Other / unclassified 400 ml Intravenous